Cargando…
Therapeutic Implications of GIPC1 Silencing in Cancer
GIPC1 is a cytoplasmic scaffold protein that interacts with numerous receptor signaling complexes, and emerging evidence suggests that it plays a role in tumorigenesis. GIPC1 is highly expressed in a number of human malignancies, including breast, ovarian, gastric, and pancreatic cancers. Suppressio...
Autores principales: | Chittenden, Thomas W., Pak, Jane, Rubio, Renee, Cheng, Hailing, Holton, Kristina, Prendergast, Niall, Glinskii, Vladimir, Cai, Yi, Culhane, Aedin, Bentink, Stefan, Schwede, Mathew, Mar, Jessica C., Howe, Eleanor A., Aryee, Martin, Sultana, Razvan, Lanahan, Anthony A., Taylor, Jennifer M., Holmes, Chris, Hahn, William C., Zhao, Jean J., Iglehart, J. Dirk, Quackenbush, John |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012716/ https://www.ncbi.nlm.nih.gov/pubmed/21209904 http://dx.doi.org/10.1371/journal.pone.0015581 |
Ejemplares similares
-
iBBiG: iterative binary bi-clustering of gene sets
por: Gusenleitner, Daniel, et al.
Publicado: (2012) -
Stem Cell-Like Gene Expression in Ovarian Cancer Predicts Type II Subtype and Prognosis
por: Schwede, Matthew, et al.
Publicado: (2013) -
Angiogenic mRNA and microRNA Gene Expression Signature Predicts a Novel Subtype of Serous Ovarian Cancer
por: Bentink, Stefan, et al.
Publicado: (2012) -
Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects
por: Borchardt, Hannes, et al.
Publicado: (2019) -
Strength and duration of GIPC-dependent signaling networks as determinants in cancer
por: Ahmed, Tasmia, et al.
Publicado: (2020)